Cutting the cord.
Global pharm giant AstraZeneca has indefinitely suspended its phase 3 trial of a COVID-19 vaccine after one of its more than 10K participants developed transverse myelitis. | Wu, New York Times 2020
Search This Blog
With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
- Get link
- Other Apps
Comments
Post a Comment